Calidi Biotherapeutics In... (CLDI)
AMEX: CLDI
· Real-Time Price · USD
1.57
-0.04 (-2.48%)
At close: Oct 17, 2025, 3:59 PM
1.58
0.32%
After-hours: Oct 17, 2025, 04:09 PM EDT
Calidi Biotherapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Period Ending | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
Revenue | n/a | n/a | 45K | 449K |
Cost of Revenue | 1.53M | 1.26M | 274K | 94K |
Gross Profit | -1.53M | -1.26M | -229K | 355K |
Operating Income | -21.78M | -28.99M | -23.13M | -10.48M |
Interest Income | n/a | n/a | n/a | n/a |
Pretax Income | -22.2M | -29.2M | -25.42M | -10.92M |
Net Income | -22.14M | -29.22M | -25.43M | -10.93M |
Selling & General & Admin | 12.9M | 15.98M | 15.64M | 6.16M |
Research & Development | 8.88M | 13.01M | 7.26M | 4.67M |
Other Expenses | n/a | -1.26M | n/a | n/a |
Operating Expenses | 21.78M | 27.74M | 22.9M | 10.84M |
Interest Expense | 933K | 3.75M | 158K | 614K |
Selling & Marketing Expenses | n/a | n/a | -260K | n/a |
Cost & Expenses | -21.78M | 28.99M | 23.17M | 10.93M |
Income Tax Expense | 14K | 16K | 11K | 11K |
Shares Outstanding (Basic) | 664.41K | 140.16K | 70.59K | 238.63K |
Shares Outstanding (Diluted) | 664.41K | 140.16K | 70.59K | 238.63K |
EPS (Basic) | -35.7 | -207.61 | -358.8 | 14.16 |
EPS (Diluted) | -35.7 | -207.61 | -358.8 | 14.16 |
EBITDA | -21.78M | -24.2M | -25M | -9.45M |
EBIT | -21.78M | -25.45M | -25.26M | -9.61M |
Depreciation & Amortization | 791K | 1.26M | 260K | 156K |
Source: Financial Modeling Prep. Financial Sources.